OLOPATADINE HYDROCHLORIDE- olopatadine hydrochloride solution/ drops 
Apotex Corp.

----------

Drug Facts

Active ingredient

Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)

                                 

Purpose

Antihistamine

Uses

Temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.

Warnings

For external use only

Do not use

  • If solution changes color or becomes cloudy
  • If you are sensitive to any ingredient in this product
  • To treat contact lens related irritation

When using this product

  • Do not touch tip of container to any surface to avoid contamination
  • Remove contact lenses before use
  • Wait at least 10 minutes before reinserting contact lenses after use
  • Do not wear a contact lens if your eye is red

Stop use and ask a doctor ifyou experience:

  • Eye pain
  • Changes in vision
  • Increased redness of the eye
  • Itching worsens or lasts for more than 72 hours

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.  

Directions

Consult a doctor

Other information

Inactive ingredients

benzalkonium chloride 0.01%, dibasic sodium phosphate, edetate disodium dihydrate, hydrochloric acid and/or sodium hydroxide (to adjust pH), povidone, sodium chloride and water for injection

Questions?

1-800-706-5575

Principal Display Panel

ONCE DAILY RELIEF

Olopatadine HCl Ophthalmic Solution, USP 0.2%

Antihistamine

Eye Allergy Itch Relief

NDC 60505-6222-2

Bottle Label

Carton Label

OLOPATADINE HYDROCHLORIDE 
olopatadine hydrochloride solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:60505-6222
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OLOPATADINE HYDROCHLORIDE (UNII: 2XG66W44KF) (Olopatadine - UNII:D27V6190PM) Olopatadine2 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:60505-6222-21 in 1 CARTON10/06/2022
1NDC:60505-6222-12.5 mL in 1 BOTTLE, PLASTIC; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
2NDC:60505-6222-32 in 1 CARTON10/06/2022
22.5 mL in 1 BOTTLE, PLASTIC; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09091810/06/2022
Labeler - Apotex Corp. (845263701)

Revised: 12/2023
Document Id: a5cfb475-5968-b0f0-1772-b6ae0f040898
Set id: 616da51c-70f4-3f87-320f-4685ad1520fa
Version: 2
Effective Time: 20231204
 
Apotex Corp.